George L Mutter

No ORCID on file · 7 papers in corpus · active 2000-2015

Study types

  • article 4
  • book 1
  • book-chapter 1
  • other 1

Condition tags

  • endometriosis 4
article 2015
·doi:10.1097/pgp.0000000000000157

Primary sporadic gene-inactivating events within the progesterone response cascade might explain the presence of individual dyssynchronous (outlier) glands commonly observed in a secretory background. We queried morphologically dyssynchrono…

article 2014
Cancer cytopathology ·doi:10.1002/cncy.21514

BACKGROUND: ARID1A (AT-rich interactive domain 1A gene) has recently been identified as a novel tumor suppressor gene and one of the driver genes in endometrial carcinogenesis. Approximately 30% to 40% of endometrial carcinomas harbor mutat…

book 2014

Vulvar dermatoses The vulva: cysts, neoplasms and related lesions The vagina The cervix - benign and non-neoplastic conditions Colposcopy The etiology of cervical cancer Cervical precancer (intraepithelial neoplasia) Malignant tumors of the…

article 2009
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc ·doi:10.1038/modpathol.2008.204
book-chapter 2009
·doi:10.1016/b978-0-443-07477-6.50017-2
other 2008
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc ·doi:10.1038/modpathol.2008.19

Progesterone receptor modulators (PRM) are hormonally active drugs effective in the management of endometriosis and uterine leiomyomata. The endometrial effects of progestin blockade by PRMs in premenopausal women are currently being evalua…

article 2000
·doi:10.1210/jcem.85.6.6652

Frequent mutation of the PTEN tumor suppressor gene in endometrial adenocarcinoma has led to the prediction that its product, a phosphatase that regulates the cell cycle, apoptosis, and possibly cell adhesion, is functionally active within …